Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OR3O Dual Mobility System

K-Number: K220959 · 2022-08-18

Decision Date2022-08-18
Product CodeLPH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

OR3O Dual Mobility System is a medical device manufactured by Smith & Nephew, Inc.. It received FDA 510(k) clearance on 2022-08-18 under approval number K220959. The device is classified under product code LPH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OR3O Dual Mobility System?

OR3O Dual Mobility System is a medical device that received FDA 510(k) clearance on 2022-08-18. It is manufactured by Smith & Nephew, Inc.. The 510(k) number is K220959.

When was OR3O Dual Mobility System approved by the FDA?

OR3O Dual Mobility System received FDA 510(k) clearance on 2022-08-18, under approval number K220959.

What company makes OR3O Dual Mobility System?

OR3O Dual Mobility System is manufactured by Smith & Nephew, Inc..

What is the FDA product code for OR3O Dual Mobility System?

The FDA product code for OR3O Dual Mobility System is LPH.

Related Clinical Trials

Other Devices by Smith & Nephew, Inc.

View all 107 devices →

Related Devices (Code: LPH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.